Domain Associates
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital, Private Equity
Stage Focus
Early Stage, Growth, Pre-Seed, Seed, Series A, Series B, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States
Industries Focus
- Healthcare
- Life Sciences
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Healthcare Technology
- Medical Research
- Medical Equipment
- Healthcare IT
- Biopharmaceuticals
- Biomaterials
- Medical Supplies
- Bioinstrumentation
Investment Size:
500,000 to 10,000,000 USD
Investor Details Founded: 1985
Domain Associates is a venture capital firm founded in 1985, focusing exclusively on life sciences investments. With over $2.8 billion in assets under management, the firm has been involved in the formation and growth of more than 250 life-sciences companies. Their investment segments include pharmaceuticals, specialty pharmaceuticals, and medical devices, with additional interests in biomaterials, bioinstrumentation, and diagnostics. The partners collectively have nearly 200 years of experience in the healthcare and venture capital industries.
The firm's investment strategy encompasses a wide range of stages, from pre-seed to late-stage investments, including buyouts and turnaround situations. They have a global geographical focus, with investments in the United States, Europe, and Asia. Domain Associates has a diverse portfolio, including companies in biopharmaceuticals, medical devices, diagnostics, and digital health sectors. Their approach combines deep industry expertise with a strong network to identify and support innovative companies that advance human health.
Over the years, Domain Associates has achieved significant milestones, including 90 IPOs and 110 M&A events, with a combined market capitalization of $190 billion for its funded companies. This track record underscores their commitment to fostering growth and innovation in the life sciences sector, making them a prominent player in healthcare venture capital.
Requirements
- Innovative healthcare technologies
- Strong management teams
- Scalable business models
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Contact Number Hidden]
Portfolio Companies
- Amgen
- Amylin Pharmaceuticals
- BiPar Sciences
- Biosite
- Dura Pharmaceuticals
- Pharmion
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of Domain Associates?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim